JIA and Your Child's Eyes: Why the Eye Exam Matters as Much as the Joint Exam

When I tell a family their child with juvenile idiopathic arthritis needs to see an eye doctor, I usually get the same look. Their child's knee is swollen. Their wrists ache in the morning. Nobody has mentioned the eyes. Why are we adding another appointment?

Eye inflammation is the most common complication of JIA outside the joints. In the children most likely to develop it, there are no symptoms at all. No pain. No redness. Nothing you could notice by looking at your child. It gets found on an eye exam, or it gets found late.

That is why the screening schedule exists.

What uveitis actually is

Uveitis means inflammation inside the eye. It is not pink eye. It is not an infection. It is the same immune-driven inflammation that affects your child's joints, happening in the tissues inside the eye.

The form most associated with JIA is chronic anterior uveitis. It develops in roughly 10 to 20 percent of children with JIA. Usually it produces no symptoms, and usually there is nothing visible from the outside.

That makes it different from most of what we watch for. With a joint there is swelling, or a limp, or a complaint. With chronic anterior uveitis, a child can have active inflammation and feel completely fine.

Why we take it so seriously

Because uncontrolled, it damages the eye.

When chronic anterior uveitis is not controlled, it can cause sight-threatening complications including scarring inside the eye, cataracts, and glaucoma in 25 to 50 percent of affected children, and vision loss in 10 to 20 percent.

I do not raise those numbers to frighten anyone. I raise them to explain why I will not treat the eye exam as optional, and why regular monitoring is one of the few recommendations in this area that experts grade as strong even though the underlying research is limited. An eye exam carries almost no risk. Missing active inflammation carries a great deal.

Which children need screening most often

Risk is not the same for every child with JIA, which is why the schedule is individualized.

Children considered higher risk generally have all of the following:

• A JIA category associated with uveitis: oligoarthritis, rheumatoid factor-negative polyarthritis, psoriatic arthritis, or undifferentiated arthritis

• A positive ANA (antinuclear antibody)

• Onset before age 7

• JIA for four years or less

For these children, screening every three months is the recommended approach.

Children at lower or moderate risk fall into those same JIA categories but are ANA negative, were seven or older when JIA began, or have had JIA longer than four years. This group also includes children with systemic JIA, rheumatoid factor-positive polyarthritis, and enthesitis-related arthritis. Screening is generally every six to twelve months, depending on the combination of risk factors.

Two points to underline. The risk is highest early, which is exactly when a new family is most overwhelmed and most likely to let an eye appointment slide. And a lower-risk profile does not mean no screening. It means less frequent screening.

If you are not sure which group your child is in, ask us. It is a reasonable question and you deserve a clear answer.

The other kind of uveitis, the one that does hurt

There is a second form called acute anterior uveitis, and it behaves the opposite way. It comes on suddenly, usually in one eye, and it is uncomfortable. It is linked to a genetic marker called HLA-B27 and shows up in children with enthesitis-related and psoriatic arthritis.

If your child has one of those diagnoses, learn these warning signs:

• Eye pain

• Redness

• Sensitivity to light

Call us the same day if they appear. Teaching families to recognize these signs is considered standard care, because catching it early shortens the episode and reduces complications.

So depending on your child's diagnosis, you may be watching for nothing at all and relying on scheduled exams, or you may be watching for specific symptoms. Which one applies to your child is worth clarifying at your next visit.

What treatment looks like

If uveitis is found, treatment usually starts with steroid eye drops to bring the inflammation under control, then tapers once the eye settles.

Drops work, but they are not a good long-term solution on their own. Prolonged frequent use raises the pressure inside the eye and can cause cataracts. So when a child still needs ongoing drops to stay controlled, we add systemic treatment with the goal of getting off the drops rather than staying on them indefinitely.

When systemic treatment is needed, methotrexate is typically first, followed by certain biologic medications, specifically the monoclonal antibody TNF inhibitors adalimumab and infliximab. In children with severe inflammation and existing damage to the eye, starting methotrexate and a biologic together is preferred over methotrexate alone, because there is less time to lose.

Once things are quiet, we do not stop quickly. Current guidance suggests at least two years of well-controlled disease before attempting to taper systemic treatment, and tapering the drops before the systemic medication rather than the other way around.

Where integrative care fits

I want to be direct about this part.

No diet, supplement, or lifestyle change replaces eye screening or treats active uveitis. If anyone suggests otherwise, that advice could cost your child vision.

What integrative care contributes is different. It supports overall inflammatory load and general health. It helps a child tolerate and stay consistent with the medications doing the heavy lifting. It addresses the sleep, nutrition, stress and activity pieces that shape how a child feels day to day, and how well a family sustains a long treatment plan. It gives parents something to act on, which matters more than people admit when you are living with a chronic diagnosis.

The eye exam is not the negotiable part. A good plan holds both.

What to do as a parent

• Ask which risk group your child is in, and what screening interval that means

• Ask whether your child should be watching for symptoms or relying on scheduled exams. It depends on their JIA category

• Book the eye appointment before you leave the rheumatology visit

• Make sure your ophthalmologist and rheumatologist talk to each other. This care does not work without it. The ophthalmologist assesses the eye and manages drops, while we manage systemic treatment. If you are not sure whether your current team coordinates this way, that is one of the things worth asking about when choosing a pediatric rheumatologist

• Keep going after things are stable. Quiet eyes are not the same as eyes that no longer need watching

Frequently asked questions

Does juvenile idiopathic arthritis affect the eyes?

Yes. Eye inflammation, called uveitis, is the most common complication of JIA outside the joints. Chronic anterior uveitis develops in about 10 to 20 percent of children with JIA and usually produces no symptoms, which is why regular eye screening is recommended.

Would I be able to tell if my child had uveitis?

Usually not. The form most common in JIA rarely causes pain or redness and often has no visible signs, so a child can have active inflammation and feel entirely normal. It is detected on a specialized eye exam. The exception is acute anterior uveitis, seen in some JIA categories, which does cause sudden pain, redness and light sensitivity.

How often does my child need an eye exam?

It depends on their risk profile. Children at higher risk, meaning a positive ANA, onset before age 7, JIA for four years or less, and one of certain JIA categories, are generally screened every three months. Children at lower or moderate risk are typically screened every six to twelve months. Your rheumatologist can tell you which applies.

What happens if uveitis is found?

Treatment usually begins with steroid eye drops to control the inflammation. If ongoing drops are needed, systemic treatment is added, usually methotrexate first, then a biologic such as adalimumab or infliximab, with the goal of reducing long-term reliance on drops.

Can uveitis cause permanent vision loss?

It can if it goes uncontrolled, which is why screening matters. Reported rates of vision loss in children with uveitis are around 10 to 20 percent, with complications such as cataracts and glaucoma in 25 to 50 percent. Detected early and treated, outcomes are considerably better.